Skip to content
Home / News |

Here’s Why IQ-AI Ltd Share Price Skyrocketed 109.1% Higher Today

medical imaging
Simon Mugo

Shares of IQ-AI limited (LON: IQAI) today spiked 109.1% higher after the medical imaging company revealed that it had signed a letter of intent to sell its Stonechecker Software Ltd business to an international medical group.

The company revealed that the due diligence process had kicked off and that the deal if completed would include a cash payment and ongoing royalties based on future sales. The company’s StoneChecker is used to assess whether kidney stones will rapture during shockwave treatments.

The company had shifted its focus to its neuroimaging business where it has a strong leadership position in December 2019 and has been looking to offload its Stonechecker business since then.

X testing X
WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
5.0
Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

IQAI share price

Tradingview chart showing IQAI share price 05082020

The company’s stock price spiked 109% higher to trade at 7.34p having closed yesterday’s session at 3.51p.

Simon Mugo
Simon Mugo
Contributor

Simon ist Autor und Analyst für den Bereich Finanzwesen und blickt auf über sechs Jahre professionelle Erfahrung als Trader zurück. Er absolvierte einen Bachelor in Mathematik und Informatik und hat eine Leidenschaft für die Finanzmärkte. Simon handelt FX, Rohstoffe und Aktien. Er konzentriert sich auf Price Action Trading.